Xenon Pharmaceuticals Inc.
Organization details
- Legal name
- Xenon Pharmaceuticals Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- British Columbia, Canada
- Headquarters city
- Burnaby
- Headquarters country
- Canada
- Fiscal year end
- December
- Ticker symbol
- XENE
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001582313
- EIN
- 98-0661854
- Wikidata ID
- Q30253570
Board of directors
-
Dawn Svoronos · DirectorSince 2023
-
Elizabeth A. Garofalo · DirectorSince 2023
-
Gary Patou · DirectorSince 2023
-
Gillian Cannon · DirectorSince 2023
-
Ian Mortimer · Director · PRESIDENT & CEOSince 2023
-
Justin D. Gover · DirectorSince 2023
-
Mohammad Azab · DirectorSince 2023
-
Patrick Machado · DirectorSince 2023
-
Simon N. Pimstone · DirectorSince 2023
-
Steven Gannon · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 4, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
91.8%
-
94.9%
-
98.6%
-
98.7%
-
98.7%
-
98.7%
-
98.9%
-
98.9%
Board connections
5 of this board's directors also sit on 8 other boards. 8 are in the same sector.
-
ACADIA Pharmaceuticals Inc. Same sectorvia Elizabeth A. Garofalo
-
Alector Inc. Same sectorvia Elizabeth A. Garofalo
-
Alumis Inc. Same sectorvia Patrick Machado
-
Arcus Biosciences Inc. Same sectorvia Patrick Machado
-
COMPASS Pathways Plc Same sectorvia Justin D. Gover
-
Corcept Therapeutics Incorporated Same sectorvia Gillian Cannon
-
Design Therapeutics Inc. Same sectorvia Justin D. Gover
-
Lisata Therapeutics Inc. Same sectorvia Mohammad Azab
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $1,681,140
- 2 purchases by 2 insiders
- Sold, last 12 months
- $21,969,316
- 26 sales by 6 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 15, 2026 | Kelly Thomas Patrick Officer (Chief Financial Officer) | Option exercise | +7,500 | — | — |
| Sep 30, 2026 | Kelly Thomas Patrick Officer (Chief Financial Officer) | Open-market purchase | +15,000 | $37.32 | $559,740 |
| Sep 30, 2026 | Ian Mortimer Director, Officer (PRESIDENT & CEO) | Open-market purchase | +30,000 | $37.38 | $1,121,400 |
| Sep 1, 2026 | Dawn Svoronos Director | Option exercise | +5,144 | $8.15 | $41,924 |
| Aug 28, 2026 | KENNEY CHRISTOPHER JOHN Officer (Chief Medical Officer) | Open-market sale | −6,368 | $60.17 | $383,163 |
| Aug 28, 2026 | KENNEY CHRISTOPHER JOHN Officer (Chief Medical Officer) | Open-market sale | −700 | $60.98 | $42,686 |
| Aug 11, 2026 | Steven Gannon Director | Open-market sale | −10,000 | $64.06 | $640,600 |
| Jun 5, 2026 | Gary Patou Director | Open-market sale | −1,322 | $53.14 | $70,251 |
| Jun 5, 2026 | Gillian Cannon Director | Open-market sale | −1,190 | $53.14 | $63,237 |
| Jun 1, 2026 | Gary Patou Director | Option exercise | +2,645 | — | — |
| Jun 1, 2026 | Patrick Machado Director | Option exercise | +2,645 | — | — |
| Jun 1, 2026 | Justin D. Gover Director | Option exercise | +2,645 | — | — |
| Jun 1, 2026 | Elizabeth A. Garofalo Director | Option exercise | +2,645 | — | — |
| Jun 1, 2026 | Steven Gannon Director | Option exercise | +2,645 | — | — |
| Jun 1, 2026 | Gillian Cannon Director | Option exercise | +2,645 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Xenon Pharmaceuticals Inc.
Who is the CEO of Xenon Pharmaceuticals Inc.?
Ian Mortimer is Xenon Pharmaceuticals Inc.'s PRESIDENT & CEO.
How many directors are on Xenon Pharmaceuticals Inc.'s board?
Xenon Pharmaceuticals Inc.'s board has 10 directors: Dawn Svoronos, Elizabeth A. Garofalo, Gary Patou, Gillian Cannon, Ian Mortimer, Justin D. Gover, Mohammad Azab, Patrick Machado, Simon N. Pimstone and Steven Gannon.
Are Xenon Pharmaceuticals Inc. insiders buying or selling shares?
Over the last 12 months, Xenon Pharmaceuticals Inc. insiders bought $1.7 million of shares in 2 purchases and sold $22.0 million of shares in 26 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="xenon-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.